Question

I am a breastfeeding mother and i want to know if it is safe to use Mepivacainum [INN-Latin]? Is Mepivacainum [INN-Latin] safe for nursing mother and child? Does Mepivacainum [INN-Latin] extracts into breast milk? Does Mepivacainum [INN-Latin] has any long term or short term side effects on infants? Can Mepivacainum [INN-Latin] influence milk supply or can Mepivacainum [INN-Latin] decrease milk supply in lactating mothers?

Mepivacainum [INN-Latin] lactation summary

Mepivacainum [INN-Latin] usage has low risk in breastfeeding
  • DrLact safety Score for Mepivacainum [INN-Latin] is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of Mepivacainum [INN-Latin] may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that Mepivacainum [INN-Latin] may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of Mepivacainum [INN-Latin] low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using Mepivacainum [INN-Latin] We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Mepivacainum [INN-Latin] usage in lactation

Local anesthetic agent which is used for infiltration and nerve-blocking procedures included Epidural anesthesia. At latest update, published data concerning excretion into breast milk were not found. However, because its chemical structure is closely related to Bupivacaine, it is expected to occur in a non-significant level. There is controversy about the effect of drug-mediated analgesia used during the child birth (e.g. epidural injection of local anesthetics plus Fentanyl or alone) on the mature milk coming in, whether by delaying the onset of Lactogenesis phase II, or, by affecting the ability of the child for sucking. Some studies have shown a higher risk for delay of initiation of Lactogenesis phase II (milk coming in) longer than 3 post-natal days, but without effect on loss of initial weight. On other studies, the newborn infant appears to have higher risk for delay on first latch-on, higher body temperature and irritability or somnolence. Because of the latter, it is argued that those mothers would be in need of more support on breastfeeding when they have received ante or intra partum analgesia. However, other authors have failed to find the same results. There consensus on the achievement of higher milk production and higher body weight increase in the neonate with an adequate pharmacological control of pain after C-section or vaginal childbirth. Considering the fact that Mepivacainum [INN-Latin] readily crosses the placenta barrier, with a elimination-time period that is slower than adults (T ½ = 9 hours), it is safer the choice of Bupivacaine in case of prematurity or during the immediate neonatal period.

Answer by DrLact: About Mepivacainum [INN-Latin] usage in lactation

No information is available on the use of Mepivacainum [INN-Latin] during breastfeeding. Based on the low excretion of other local anesthetics into breastmilk, a single dose of Mepivacainum [INN-Latin] during breastfeeding is unlikely to adversely affect the breastfed infant. However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Mepivacainum [INN-Latin] given during labor as a local anesthetic to the mother has been reported to interfere with initial nursing behavior of some infants, but not weight gain during the first 5 days postpartum. Labor pain medication may delay the onset of lactation. More study is required to clarify the effect of Mepivacainum [INN-Latin] during labor on breastfeeding outcome.

Mepivacainum [INN-Latin] Possible Effects in Breastfeeding

In a study that compared extradural administration of Mepivacainum [INN-Latin], bupivacaine and lidocaine for analgesia during normal childbirth, no differences were found in weight changes over the first 5 days after delivery among the breastfed infants of the 3 groups. Overall weight gain was within normal limits for all groups.[1] Of 6 infants whose mothers received a pudendal block with Mepivacainum [INN-Latin] within the hour before delivery, 4 took longer to begin nursing behavior and nursed less initially than 10 infants whose mothers received no anesthesia during labor. The long-term consequences of these differences were not reported.[2] A national survey of women and their infants from late pregnancy through 12 months postpartum compared the time of lactogenesis II in mothers who did and did not receive pain medication during labor. Categories of medication were spinal or epidural only, spinal or epidural plus another medication, and other pain medication only. Women who received medications from any of the categories had about twice the risk of having delayed lactogenesis II (>72 hours) compared to women who received no labor pain medication.[3]

Alternate Drugs

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.